PTPA and hepatoblastoma: This study showed for the first time that FTY720 resulted in PP2A activation and decreased HuH6 hepatoblastoma cell viability, proliferation, and motility, increased apoptosis in vitro, and decreased hepatoblastoma tumor growth in vivo.